Schedule 13D ownership disclosure

Aurinia Pharmaceuticals Inc

Security class unavailable · CUSIP: 05156V102

Event date: 2019-12-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,877,616
Percent of class
9.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-071472
Form type
SC 13D/A
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Dec 10, 2019
Reporting period
Dec 09, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub